ArticleScientific reports2026
Spatial profiling of chronic liver disease: a pilot spatial case series.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The spatial organization of chronic liver disease across major etiologic contexts remains incompletely understood. Here we present a pilot spatial case series using sequencing-based spatial transcriptomics to examine alcohol-associated liver disease (ALD), metabolic dysfunction-associated steatohepatitis (MASH), and chronic hepatitis C within preserved histological context. Eight liver tissues were profiled using a viral-aware workflow enabling in situ detection of hepatitis viral RNA, histology-guided niche annotation, and cell-cell communication analysis; four cases passed quality control and were included in the core discovery analyses. In HCV case, viral reads localized to immune-enriched microenvironments and extended into adjacent regions enriched for cell-cycle, RNA-processing, and PD-1-axis checkpoint pathways. In ALD and MASH tissues, histology-guided segmentation aligned with transcriptomic clusters, and pseudolobular sub-clustering identified recurrent functional compartments. Across the analyzed cases, immune-mesenchymal signaling hubs associated with extracellular matrix and chemokine programs were observed. Overall, this pilot spatial case series suggests that chronic liver disease tissues may share recurrent pseudolobular functional architecture, upon which etiology-associated immune, metabolic, and viral-response programs are superimposed in a case-dependent manner. Supplementary analyses summarize additional feasibility observations from HBV-profiled sections that did not support inclusion in the core downstream analyses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.